Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc. (ticker: ASBP) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of ASBP's SEC filings surfaces 5 active risk signals, including 3 late-filing signals, 1 auditor-change signal, and 1 delisting/deregistration signal. ASBP reported $6K in revenue and -$24.48M for the period ending 2025-12-31, with operating cash flow of -$4.92M. Cash and equivalents stood at $1.00M (up 27532.9% year-over-year). Total assets of $1.31M are exceeded by total liabilities of $7.69M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.